Teza Capital Management LLC increased its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 233.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,469 shares of the financial services provider's stock after purchasing an additional 2,429 shares during the quarter. Teza Capital Management LLC's holdings in CME Group were worth $920,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of CME. GQG Partners LLC raised its holdings in CME Group by 7,676.3% in the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock worth $584,975,000 after purchasing an additional 2,176,685 shares during the period. Wellington Management Group LLP increased its stake in CME Group by 370.5% in the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock worth $704,068,000 after buying an additional 2,089,935 shares in the last quarter. GAMMA Investing LLC increased its stake in CME Group by 32,941.0% in the 1st quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock worth $493,144,000 after buying an additional 1,853,261 shares in the last quarter. Nuveen LLC purchased a new stake in CME Group in the 1st quarter worth $218,842,000. Finally, Alliancebernstein L.P. increased its stake in CME Group by 185.5% in the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider's stock worth $330,182,000 after buying an additional 808,740 shares in the last quarter. 87.75% of the stock is owned by institutional investors.
CME Group Trading Down 2.1%
CME opened at $261.94 on Friday. The firm has a market cap of $94.40 billion, a P/E ratio of 25.36, a P/E/G ratio of 4.74 and a beta of 0.43. CME Group Inc. has a 12 month low of $212.38 and a 12 month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a 50-day moving average of $274.96 and a 200 day moving average of $269.99.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm's revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the business posted $2.56 earnings per share. As a group, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be given a $1.25 dividend. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group's dividend payout ratio (DPR) is currently 48.40%.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on CME shares. Piper Sandler increased their price target on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Barclays set a $298.00 price target on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Oppenheimer raised their price objective on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research report on Thursday, July 24th. Finally, Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, CME Group presently has an average rating of "Hold" and a consensus target price of $261.93.
Get Our Latest Report on CME Group
Insider Buying and Selling
In related news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the completion of the transaction, the director owned 4,900 shares of the company's stock, valued at approximately $1,300,215. This represents a 9.26% decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report